Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Go back to Helus Pharma Appoints Michael Halstead as Chief Executive Officer
(NASDAQ: HELP) Delayed: 11.67 +0.10 (0.86%)
Previous Close $11.57    52 Week High
Open $11.56    52 Week Low
Day High $11.77    P/E N/A 
Day Low $11.17    EPS
Volume 991,804